Report: The Top 10 Medical Equipment Market Trends TOC

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 11
2.1 What is this Report About? 11
2.2 Global Markets Direct Report Coverage 11
2.3 Definitions 12
2.3.1 Cardiovascular Devices 12
2.3.2 Orthopedic Devices 12
2.3.3 Diagnostic Imaging 12
2.3.4 Ophthalmic Devices 12
2.3.5 In-vitro Diagnostics 12
2.3.6 Patient Monitoring Devices 12
2.3.7 Dental Devices 13
2.3.8 Endoscopy Devices 13
2.3.9 Hospital Supplies 13
2.3.10 Nephrology and Urology Devices 13
2.3.11 Diabetes Care Devices 13
2.3.12 Wound Care Management 13
2.3.13 Neurology Devices 14
2.3.14 Surgical Equipment 14
2.3.15 Anesthesia and Respiratory Devices 14
2.3.16 ENT Devices 14
2.3.17 Drug Delivery Devices 14
2.3.18 Healthcare IT 14
3 Top 10 Medical Equipment Market Trends 15
3.1 Executive Summary 16
4 Industry Consolidations Would Re-Shape The Medical Equipment Competitive Landscape 18
4.1 Overview 18
4.2 Medical Equipment Consolidation Landscape in 2007 19
4.3 Mergers 22
4.3.1 Impact Analysis 23
4.4 Acquisitions 26
4.4.1 Impact Analysis 27
4.5 Partnerships 29
4.5.1 Impact Analysis 30
4.6 Future Outlook 32
4.6.1 Johnson & Johnson to strengthen its cardiovascular devices portfolio 33
5 Direct To Consumer Advertising: A New Marketing Weapon Or A Sign Of Desperation? 39
5.1 Overview 39
5.2 Direct to Consumer Advertising: A Trend Analysis 41
5.3 Strategic Rationale behind Medtronic' s DTC Advertising Campaign 42
5.4 Strategic Rationale behind Johnson & Johnson' s DTC Advertising Campaign 42
5.5 Future Outlook 44
5.5.1 Life-saving Medical Devices 44
5.5.2 Life-style Medical Devices 45
6 Device Recalls & Safety Alerts: Market Impact Outlook And The Post-Marketing Strategies That The Manufacturers Could Opt 47
6.1 Overview 47
6.2 Implantable cardioverter-defibrillators 48
6.2.1 Trend Analysis 48
6.2.2 Impact Analysis and Future Outlook 49
6.3 Drug Eluting Stents 50
6.3.1 Trend Analysis 50
6.3.2 Impact Analysis and Future Outlook 50
6.4 Hip Resurfacing Implants 53
6.4.1 Trend Analysis 53
6.4.2 Impact Analysis and Future Outlook 53
6.5 US FDA' s likely position 55
6.6 What could the manufacturer' s do 55
7 Companies To Watch Out For 57
7.1 Overview 57
7.2 Leading Players 58
7.2.1 Johnson & Johnson 58
7.2.2 GE Healthcare 60
7.2.3 Siemens Medical Solutions 62
7.2.4 Boston Scientific 64
7.2.5 F. Hoffmann-La Roche Ltd 66
7.2.6 Abbott Laboratories 66
7.3 Emerging Players 67
7.3.1 Biosensors International Group Ltd. 67
7.3.2 Integra Life Sciences 68
7.3.3 Inverness Medical Innovations, Inc. 69
7.3.4 Teleflex Medical 70
7.3.5 Wright Medical Technology, Inc. 70
8 Products To Watch Out For 72
8.1 Overview 72
8.2 Marketed Devices 73
8.2.1 ProDisc™-C Total Disc Replacement 73
8.2.2 Exponent® Self-Expanding Carotid Stent with Over-the-Wire (OTW) or Rapid-Exchange (RX) Delivery Systems 75
8.2.3 GeneSearch™ BLN Test Kit 76
8.2.4 PRESTIGE® Cervical Disc System 76
8.2.5 Cormet™ Hip Resurfacing System 77
8.2.6 INRange Remote Medication Management System 77
8.2.7 STS-7 Continuous Glucose Monitoring System 78
8.2.8 CORDIS ENTERPRISE™ Vascular Reconstruction Device and Delivery System 78
8.2.9 PROBEAT WITH DISCRETE SPOT SCANNING SYSTEM 79
8.2.10 Endeavor® Zotarolimus-Eluting Coronary Stent System 80
8.3 Devices under clinical investigation 80
8.3.1 XIENCE™ V Everolimus Eluting Coronary Stent System 80
9 Home And Self Care To Gain Prominence 81
9.1 Overview 81
9.2 Trend Analysis 82
9.2.1 Major medical equipment markets moving towards Home and Self Care 82
9.2.2 Factors driving the movement from Hospital Care to Home and Self Care 90
9.3 Future Outlook 94
9.3.1 Future Trends & Drivers 94
9.3.2 Emerging Leaders in Home & Self Care 94
10 Drug And Device Combinations Would Continue To Attract Adoption 96
10.1 Overview 96
10.2 Regulatory Scenario 96
10.3 Upcoming Market Sectors 97
10.3.1 Drug Delivery Devices 97
10.3.2 Bone Cement with antibiotics 98
10.3.3 Bone Graft Substitutes 100
10.3.4 Biological wound treatment products 101
10.3.5 Photodynamic therapy 102
10.4 Impact Analysis 103
11 Minimally Invasive Surgery Set To Experience Increased Acceptence 104
11.1 Studies in the news 105
11.2 Leading Companies 106
11.2.1 Karl Storz 107
11.2.2 Olympus 107
11.2.3 Smith & Nephew 107
11.2.4 Stryker 108
11.2.5 Gyrus 108
11.2.6 Pentax 108
11.2.7 Fujinon 109
11.2.8 Ethicon 109
11.3 Innovations in Minimally Invasive Devices 109
11.3.1 NuBoom 109
11.3.2 SpineWand® from Arthrocare 109
11.3.3 Capsule Endoscope 109
11.4 Future Outlook and Implications 110
12 VC Financing To Be More Robust 111
12.1 Overview 111
12.2 VC Firms likely to remain active in the near future 112
12.2.1 Alta Partners 112
12.2.2 Delphi Ventures 112
12.2.3 Foundation Medical Partners 113
12.2.4 Advanced Technology Ventures 113
12.2.5 InterWest Partners 114
12.2.6 New Enterprise Associates 115
12.3 Markets that could attract major VC Financings 115
12.3.1 Cardiovascular Devices 115
12.3.2 Orthopedic Devices 117
12.3.3 Diagnostic Imaging 118
12.3.4 In-vitro Diagnostics 119
13 Predicting the Regulatory Landscape 121
13.1 USA 121
13.1.1 Regulatory Landscape in 2007 121
13.1.2 Future Outlook 121
13.2 European Union 124
13.2.1 CE Mark Directives Amendment 124
13.2.2 Medical Device Vigilance Guidelines 125
13.3 Japan 127
13.3.1 Global Clinical Trials 127
13.4 Emerging Economies 128
13.4.1 Latin American Medical Equipment Regulations 128
13.4.2 Indian Medical Equipment Regulations 129
13.4.3 Chinese Medical Equipment Regulations 129
14 Appendix 132
14.1 Methodology 132
14.2 Coverage 133
14.3 Secondary Research 133
14.4 Primary Research 134
14.5 Models 134
14.6 Forecasts 135
14.7 Expert Panels 135
14.8 Sources 135
14.9 Abbreviations 136
14.10 Notes 137
14.11 Contact Us 137
14.12 Disclaimer 137

1.1 List of Tables
Table 1: Company Share by Revenue in the US Drug Eluting Stent Market ($b), 2004-2007 32
Table 2: Overall Revenues in the Global Cardiac Rhythm Management Market ($b), 2000-2011 33
Table 3: Major DTC Advertising Campaigns 41
Table 4: Overall Revenues in the US Defibrillators Market ($b), 2000 -- 2007 49
Table 5: Overall Revenues in the US Coronary Stents Market ($b), 2000 -- 2006 52
Table 6: Overall Revenues in the US Hip Resurfacing Implants Market ($m), 2006 -- 2012 54
Table 7: Overall Revenues in the Global Hip and Knee Implants Market ($b), 2002 -- 2008 60
Table 8: Overall Revenues in the Global Orthobiologics Market ($b), 2000 -- 2011 69
Table 9: Overall Revenues in the US Spinal Surgery Implants Market ($b), 2000 -- 2011 74
Table 10: Overall Revenues in the US Peripheral Vascular Stent Market ($m), 2000 -- 2011 76
Table 11: Overall Revenues in the US Interventional Neurology Devices Market ($m), 2000 -- 2011 79
Table 12: Overall Revenues in the Global Home and Self Care Medical Device Market ($m), 2000 -- 2011 82
Table 13: Overall Revenues in the Global Drug Delivery Devices Market ($b), 2000 -- 2011 98
Table 14: Overall Revenues in the Global Bone Cement Market ($m), 2000 -- 2011 98
Table 15: Overall Revenues in the Global Bone Graft Substitutes Market ($b), 2000 -- 2011 101
Table 16: Overall Revenues in the Global Advanced Wound Management Market ($b), 2000 -- 2011 102
Table 17: Overall Revenues in the Global Endoscopy Devices Market ($b), 2000 - 2011 105
Table 18: Overall Revenues in the Global Cardiovascular Devices Market ($b), 2000 -- 2011 116
Table 19: Overall Revenues in the Global Orthopedic Devices Market ($b), 2000 -- 2011 117
Table 20: Overall Revenues in the Global Diagnostic Imaging Market ($b), 2000 -- 2011 119
Table 21: Overall Revenues in the Global In-vitro Diagnostics Market ($b), 2000 -- 2011 119

1.2 List of Figures
Figure 1: Market Growth Potential Framework 19
Figure 2: Financial Deals by Medical Equipment Market, 2007 20
Figure 3: Financial Deals by type, 2007 21
Figure 4: Deal Type and Impact 22
Figure 5: Mergers by medical equipment market, 2007 23
Figure 6: Hologic and Cytyc Corporation: Merger Impact 24
Figure 7: ev3 and Foxhollow Technologies: Merger Impact 25
Figure 8: Acquisitions by medical equipment market, 2007 26
Figure 9: Siemens' acquisition of Dade Behring and Bayer Diagnostics: Acquisition Impact 27
Figure 10: Olympus' acquisition of Gyrus Group: Acquisition Impact 28
Figure 11: Partnerships by medical equipment market, 2007 29
Figure 12: Partnerships by type, 2007 30
Figure 13: Drug Eluting Stent Market and Competitive Landscape in the US, 2004 -- 2007 31
Figure 14: Overall Revenues in the Global Cardiac Rhythm Management Market ($b), 2000-2011 34
Figure 15: Market Capitalization, Johnson & Johnson 35
Figure 16: Market Capitalization, Boston Scientific 36
Figure 17: Market Capitalization, Medtronic, Inc. 37
Figure 18: Market Capitalization, St Jude Medical 38
Figure 19: Media Penetration by type, US 40
Figure 20: DTC Marketing Spend: Purpose and Drivers 44
Figure 21: Device Recalls initiated by the US FDA, 2002 -- 2007 47
Figure 22: Overall Revenues in the US Defibrillators Market ($b), 2000 -- 2007 49
Figure 23: Overall Revenues in the US Coronary Stents Market ($b), 2000 -- 2006 52
Figure 24: Overall Revenues in the US Hip Resurfacing Implants Market ($m), 2006 -- 2012 54
Figure 25: Company Scorecard & Impact Outlook, 2008 57
Figure 26: Overall Revenues in the Global Hip and Knee Implants Market ($b), 2002 -- 2008 59
Figure 27: Diagnostic Devices Competitive Landscape, Pre -- Acquisition of Abbott (Diagnostics) 61
Figure 28: Diagnostic Devices Competitive Landscape, Post -- Acquisition of Abbott (Diagnostics)* 62
Figure 29: IVD Competitive Landscape, Pre-Acquisition of Dade Behring 63
Figure 30: IVD Competitive Landscape, After the Acquisition of Dade Behring 64
Figure 31: Boston Scientific, Product Pipeline and Expected Launches in 2008 65
Figure 32: Overall Revenues in the Global Orthobiologics Market ($b), 2000 -- 2011 68
Figure 33: Medical Device Approvals, 2002-2007 72
Figure 34: Overall Revenues in the US Spinal Surgery Implants Market ($b), 2000 -- 2011 74
Figure 35: Overall Revenues in the US Peripheral Vascular Stent Market ($m), 2000 -- 2011 75
Figure 36: Overall Revenues in the US Interventional Neurology Devices Market ($m), 2000 -- 2011 79
Figure 37: Home and Self Care Device Portfolio Analysis 81
Figure 38: Overall Revenues in the Global Diabetes Care Devices Market ($b), 2000 -- 2011 83
Figure 39: Overall Revenues in the Global Home and Self Care Drug Delivery Devices Market ($b), 2000 -- 2011 84
Figure 40: Overall Revenues in the Global Self Testing (IVD) Market ($b), 2000 -- 2011 85
Figure 41: Overall Revenues in the Global Home and Self Care Anesthesia and Respiratory Devices Market ($b), 2000 -- 2011 86
Figure 42: Overall Revenues in the Global Peritoneal Dialysis Solutions Market ($b), 2000 -- 2011 87
Figure 43: Overall Revenues in the Global Incontinence Devices Market ($b), 2000 -- 2011 88
Figure 44: Overall Revenues in the Global Hearing Aid Devices Market, Global ($b), 2000 -- 2011 89
Figure 45: Factors driving the movement from Hospital Care to Home and Self Care 90
Figure 46: Aging Population (65+) Growth, Emerging Economies vs. Developed Economies 91
Figure 47: GDP Per Capita, Emerging Economies vs. Developed Economies, 2007 92
Figure 48: Aging Population Per Doctor and Hospital Ward, Selected Economies* 93
Figure 49: Overall Revenues in the Global Drug Delivery Devices Market ($b), 2000 -- 2011 97
Figure 50: Overall Revenues in the Global Bone Cement Market ($m), 2000 -- 2011 99
Figure 51: Overall Revenues in the Global Bone Graft Substitutes Market ($b), 2000 -- 2011 100
Figure 52: Overall Revenues in the Global Advanced Wound Management Market ($b), 2000 -- 2011 102
Figure 53: Overall Revenues in the Global Endoscopy Devices Market ($b), 2000 - 2011 104
Figure 54: Endoscopy Devices Market Split, 2007 105
Figure 55: Minimally Invasive Devices Market, Company Share (%), 2006 106
Figure 56: VC Financings by Market, 2007 111
Figure 57: Overall Revenues in the Global Cardiovascular Devices Market ($b), 2000 -- 2011 116
Figure 58: Overall Revenues in the Global Orthopedic Devices Market ($b), 2000 -- 2011 117
Figure 59: Overall Revenues in the Global Diagnostic Imaging Market ($b), 2000 -- 2011 118
Figure 60: Overall Revenues in the Global In-vitro Diagnostics Market ($b), 2000 -- 2011 120
Figure 61: New Vigilance Guideline Terminologies, 2007 126
Figure 62: Reporting Timelines in the New Vigilance Guideline, 2007 127
Figure 63: Global Markets Direct Methodology 132